Paid Clinical Trials in Salt Lake City, UT
As of August 2026, 937 paid clinical trials are recruiting in Salt Lake City, Utah. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Salt Lake City offers studies at sites including University of Utah for conditions such as Breast Cancer, Acute Myeloid Leukemia, Advanced Solid Tumor, Multiple Myeloma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Salt Lake City
Trials by drug in Salt Lake City
Filter results
Newly added in Salt Lake City
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Digital Health Implementation Strategies to Improve Lung Cancer Screening Among Safety-Net Clinics
Safety, Tolerability, and PK of AH-008 Following Single Ascending Dose in Healthy Subjects
Digital Technology-Informed Stroke Rehabilitation
Superiority Trial of Aphasia-focused Rehabilitation With tDCS Stimulation
Financial Counseling for Dementia Family Caregivers in Early and Middle Adulthood
825 clinical trials
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
Top Research Study Locations in Salt Lake City
Researchers run research studies in Salt Lake City, UT at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Utah | Acute Myeloid Leukemia, Cancer, Heart Diseases | 206 |
| Huntsman Cancer Institute/University of Utah | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8 | 71 |
| Primary Children's Hospital | Neuroblastoma, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia | 62 |
| Huntsman Cancer Institute | Multiple Myeloma, Colorectal Cancer, Endometrial Cancer | 59 |
| Huntsman Cancer Institute, University of Utah | Advanced Solid Tumor, Breast Cancer, HIV Infection | 32 |
| University of Utah Health | Heart Failure, Interstitial Lung Disease, Progressive Pulmonary Fibrosis | 29 |
| University of Utah Hospital | Cardiovascular Diseases, Abdominal Aortic Aneurysm, Cirrhosis | 20 |
| Huntsman Cancer Institute at University of Utah | Gynecologic Cancer, Breast Cancer, Breast Cancer Female | 19 |
| University of Utah Sugarhouse Health Center | Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | 16 |
| VA Salt Lake City Health Care System, Salt Lake City, UT | Alcohol Use Disorder, Alcohol Use Disorder (AUD), Atherosclerosis | 15 |
| Huntsman Cancer Institute at the University of Utah | Multiple Myeloma, Non-Hodgkin Lymphoma, Plasma Cell Leukemia | 15 |
| LDS Hospital | ANCA Associated Vasculitis (AAV), Carbon Monoxide Poisoning, Cardiovascular Diseases | 14 |
| The University of Utah | Bowel; Stricture, Cardiovascular Disease and Lipoprotein(a), Cerebral Palsy | 11 |
| University of Utah Huntsman Cancer Institute | Advanced Melanoma, Breast Cancer, ARID1A Gene Mutation | 11 |
| Utah Cancer Specialists | Colorectal Cancer, NSCLC, Ovarian Cancer | 11 |
| Intermountain Healthcare | Large B-cell Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma | 10 |
| University of Utah Orthopaedic Center | Acetabular Fracture, Chronic Low-back Pain, Chronic Pain | 8 |
| Intermountain Health | Sepsis, Septic Shock, Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma | 7 |
| University of Utah - Huntsman Cancer Institute | Advanced Solid Tumor, Bladder Cancer, Breast Cancer | 7 |
| University of Utah Orthopedics | Ankle Injuries, Cervical Myelopathy, Early Mobilization | 7 |
| St. Mark's Hospital | Persistent Atrial Fibrillation, AV Block, Atrial Fibrillation | 6 |
| University of Utah Healthcare | Intracerebral Hemorrhage, Atrial Fibrillation, Ischemic Stroke | 6 |
| University of Utah Medical Center | Obstetrical Complications, HCV, Liver Transplant | 6 |
| Clinical Trial Site | Acute Hepatic Porphyria, Breast Cancer, ER Positive Breast Cancer | 5 |
| George E Wahlen Department of Veterans Affairs Medical Center | Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm, Acute Myeloid Leukemia Post Cytotoxic Therapy | 5 |
Active & Upcoming Studies in Salt Lake City (2026)
Recruiting trials in Salt Lake City grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (298 active studies)
- A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma · Phase 3 · AbbVie
- Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02) · Phase 3 · Bristol-Myers Squibb
Neurology & pain (75 active studies)
- Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease · Phase 4 · VA Office of Research and Development
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Cardiovascular (61 active studies)
- BOdygUardian MOnitoriNg for ReCurrencE of AF · Heart Rhythm Clinical and Research Solutions, LLC
- Autus Valve Continued Access Study (CAS) · Edwards Lifesciences
Diabetes & metabolic (30 active studies)
- Partnership to Reduce Obesity in Community Health Center Patients (SMARTLife Utah) · University of Utah
- A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2) · Phase 3 · Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Eye & vision (25 active studies)
- Study of Serine Supplementation to Protect Vision in MacTel · Phase 3 · The Lowy Medical Research Institute Limited
- Lesion-tailored, Fundus-controlled Perimetry in Geographic Atrophy (GA). · University of Utah
Pediatric (21 active studies)
- A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction · Phase 3 · Bayer
- A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study · Carelon Research
Mental health & behavior (18 active studies)
- Interprofessional Simulation Program for Clinical Resilience and Empathy: Project INSPIRE · University of Utah
- Brief Postoperative Pain Management Intervention: Meaning Making Amendment · University of Utah
Vaccines (8 active studies)
HIV / STI (4 active studies)
- Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma · Phase 1 · AIDS Malignancy Consortium
- Screen Smart: Using Digital Health to Improve HIV Screening and Prevention · Children's Hospital Medical Center, Cincinnati
Common conditions studied in Salt Lake City
- Breast Cancer (21 active studies)
- Acute Myeloid Leukemia (13 active studies)
- Advanced Solid Tumor (12 active studies)
- Multiple Myeloma (12 active studies)
- Heart Failure (10 active studies)
- Obesity (10 active studies)
Leading research sponsors in Salt Lake City
- University of Utah
- National Cancer Institute (NCI)
- Novartis Pharmaceuticals
- VA Office of Research and Development
- Children's Oncology Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Salt Lake City?
There are approximately 937 recruiting clinical trials in Salt Lake City, Utah listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Salt Lake City pay participants?
Most recruiting trials in Salt Lake City compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Salt Lake City?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Salt Lake City?
The most common conditions under active study in Salt Lake City include Breast Cancer (21), Acute Myeloid Leukemia (13), Advanced Solid Tumor (12), Multiple Myeloma (12), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Salt Lake City?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Salt Lake City on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Salt Lake City?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Salt Lake City?
Recruiting research sites in Salt Lake City include University of Utah, Huntsman Cancer Institute/University of Utah, Primary Children's Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Salt Lake City right now?
The largest active categories in Salt Lake City are Cancer & tumors (298), Neurology & pain (75), Cardiovascular (61). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.